Unlabelled: Microvesicles, so-called endothelial large extracellular vesicles (LEVs), are of great interest as biological markers and cell-free biotherapies in cardiovascular and oncologic diseases. However, their therapeutic perspectives remain limited due to the lack of reliable data regarding their systemic biodistribution after intravenous administration.
Methods: Applied to a mouse model of peripheral ischemia, radiolabeled endothelial LEVs were tracked and their in vivo whole-body distribution was quantified by microSPECT/CT imaging. Hindlimb perfusion was followed by LASER Doppler and motility impairment function was evaluated up to day 28 post-ischemia.
Results: Early and specific homing of LEVs to ischemic hind limbs was quantified on the day of ischemia and positively correlated with reperfusion intensity at a later stage on day 28 after ischemia, associated with an improved motility function.
Conclusions: This concept is a major asset for investigating the biodistribution of LEVs issued from other cell types, including cancer, thus partly contributing to better knowledge and understanding of their fate after injection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778059 | PMC |
| http://dx.doi.org/10.3390/pharmaceutics14010121 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of a Vascular Endothelial Growth Factor Receptor-3 Binding Peptide TMVP1 for Enhancing Drug Delivery Efficiency and Therapeutic Efficacy Against Tumor Lymphangiogenesis.
Cancer Biother Radiopharm
December 2024
Department of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Vascular endothelial growth factor receptor-3 (VEGFR-3) plays an indispensable role in lymphangiogenesis. Previous findings suggest that blocking the VEGFR-3 signaling pathway can inhibit lymph node metastasis effectively, thus reducing the incidence of distant metastasis. The development of new VEGFR-3-targeting drugs for early detection and effective treatments is, therefore, urgently required.
View Article and Find Full Text PDFMolecular signature-based labeling techniques for vascular endothelial cells.
Acta Histochem
December 2024
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Ahmedabad, Gandhinagar, Gujarat 382355, India. Electronic address:
Vascular endothelial cells (VECs) play a crucial role in the development and maintenance of vascular biology specific to the tissue types. Molecular signature-based labeling and imaging of VECs help researchers understand potential mechanisms linking VECs to disease pathology, serving as valuable biomarkers in clinical settings and trials. Labeling techniques involve selectively tagging or marking VECs for visualization.
View Article and Find Full Text PDFTranscellular transport of F-deoxyglucose via facilitative glucose channels in experimental peritoneal dialysis.
Perit Dial Int
December 2024
Nephrology Division, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.
Background: Local and systemic side effects of glucose remain major limitations of peritoneal dialysis (PD). Glucose transport during PD is thought to occur via inter-endothelial pathways, but recent results show that phloretin, a general blocker of facilitative glucose channels (glucose transporters [GLUTs]), markedly reduced glucose diffusion capacity indicating that some glucose may be transferred via facilitative glucose channels (GLUTs). Whether such transport mainly occurs into (absorption), or across (trans-cellular) peritoneal cells is as yet unresolved.
View Article and Find Full Text PDFImmuno-PET Imaging of CD93 Expression with Cu-Radiolabeled NOTA-mCD93 ([Cu]Cu-NOTA-mCD93) and Insulin-Like Growth Factor Binding Protein 7 ([Cu]Cu-NOTA-IGFBP7).
Mol Pharm
December 2024
Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
CD93 is overexpressed in multiple solid tumor types, serving as a novel target for antiangiogenic therapy. The goal of this study was to develop a Cu-based positron emission tomography (PET) tracer for noninvasive imaging of CD93 expression. Antimouse-CD93 mAb (mCD93) and the CD93 ligand IGFBP7 were conjugated to a bifunctional chelator, -isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid (-SCN-NOTA) and labeled with Cu.
View Article and Find Full Text PDFAssessing the biocompatibility and stability of CeO nanoparticle conjugates with azacrowns for use as radiopharmaceuticals.
RSC Med Chem
September 2024
Faculty of Chemistry, Lomonosov Moscow State University 119991 Leninskie Gory, 1/3 Moscow Russia
The application of nanoparticles is promising for the purposes of nuclear medicine due to the possibilities of using them as vectors and transporters of radionuclides. In this study, we have successfully synthesised conjugates of CeO nanoparticles and azacrown ligands. Then, the radiolabelling conditions with radionuclides Zn, Sc and Bi were selected and the kinetic stability of the complexes in biologically significant media was evaluated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!